IR-Med (IRME) Total Debt Growth (1y) (2021 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | IR-Med | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 16.77% |
| Dec 31, 2023 | -20.30% |
| Sep 30, 2023 | -4.40% |
| Jun 30, 2023 | 5.62% |
| Mar 31, 2023 | -68.29% |
| Dec 31, 2022 | 14.12% |
| Sep 30, 2022 | -6.47% |
| Dec 31, 2021 | 6.63% |